Metabolic syndrome related cardiovascular disease risk in schizophrenia

Basit Öğe Kaydı
dc.contributor.authorAltinbas, K.
dc.contributor.authorYesilyurt, S.
dc.contributor.authorIpek, H. I.
dc.date.accessioned2025-01-27T21:06:04Z
dc.date.available2025-01-27T21:06:04Z
dc.date.issued2014
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description27th Congress of the European-College-of-Neuropsychopharmacology (ECNP) -- OCT 18-21, 2014 -- Berlin, GERMANY
dc.description.abstract[Anstract Not Available]
dc.description.sponsorshipEuropean Coll Neuropsychopharmacol
dc.identifier.doi10.1016/S0924-977X(14)70923-X
dc.identifier.endpageS577
dc.identifier.issn0924-977X
dc.identifier.issn1873-7862
dc.identifier.startpageS576
dc.identifier.urihttps://doi.org/10.1016/S0924-977X(14)70923-X
dc.identifier.urihttps://hdl.handle.net/20.500.12428/27888
dc.identifier.volume24
dc.identifier.wosWOS:000362851800056
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier Science Bv
dc.relation.ispartofEuropean Neuropsychopharmacology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.titleMetabolic syndrome related cardiovascular disease risk in schizophrenia
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu